← All stocks

AbbVie

ABBV Net selling
CIK 0001551152 #14 in the set updated 17 Sep 2026
Bought (120 mo)
$14.28M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$746.78M
$15.00M on a plan · $502.72M straight out of an exercise
Sold at will
$229.06M
157 of 309 sales
Net
−$732.50M
−$214.78M against sales at will

By person

36 insiders · 328 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GONZALEZ RICHARD A
Director
$233.01M (58) scheduled
−$233.01M
392,379
$98.09M
+24.5%
SEVERINO MICHAEL
Vice Chairman
$104.33M (22) scheduled
−$104.33M
152,103
$38.03M
+85.8%
RICHMOND TIMOTHY J.
EVP, CHIEF HR OFFICER
$71.94M (29) scheduled
−$71.94M
6,130
$1.53M
−35.1%
Schumacher Laura J
Vice Chairman
$1.76M (1)
$61.93M (25) scheduled
−$60.17M
248,002
$62.00M
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
$1.00M (1)
$45.08M (15) scheduled
−$44.08M
83,171
$20.79M
+182.1%
SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER
$41.42M (18) scheduled
−$41.42M
201,667
$50.42M
+274.1%
ALBAN CARLOS
Vice Chairman
$32.57M (9) scheduled
−$32.57M
114,899
$28.72M
−23.1%
Gosebruch Henry O
EVP, Chief Strategy Officer
$2.02M (1)
$29.66M (46)
−$27.64M
216,735
$54.18M
+1.9%
Siatis Perry C
EVP, GC AND SECRETARY
$24.22M (18) scheduled
−$24.22M
4,619
$1.15M
−55.5%
Michael Robert A.
CHAIRMAN OF THE BOARD AND CEO
$20.10M (10) scheduled
−$20.10M
178,737
$44.68M
+718.5%
Sorg Elaine K.
SVP, US COMMERCIAL OPERATIONS
$15.64M (18) scheduled
−$15.64M
35,330
$8.83M
+100.8%
CHASE WILLIAM J
EVP, Finance & Administration
$2.05M (1)
$16.61M (5)
−$14.56M
169,552
$42.39M
−1.6%
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
$498.06K (1)
$14.98M (5) scheduled
−$14.49M
74,430
$18.61M
+64.7%
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
$8.70M (4)
−$8.70M
38,777
$9.69M
+4,693%
Strom Carrie C
SVP & PRES GLOBAL ALLERG AESTH
$5.73M (9) scheduled
−$5.73M
28,024
$7.01M
Buckbee Kevin K
SVP, CONTROLLER
$5.07M (4) scheduled
−$5.07M
7,797
$1.95M
+82.7%
AUSTIN ROXANNE S
Director
$5.06M (4)
$9.88M (5)
−$4.82M
39,576
$9.89M
+44.9%
Durkin Brian L
VP, CONTROLLER
$255.75K (3)
$4.35M (4) scheduled
−$4.09M
33,149
$8.29M
+556.3%
Purdue David Ryan
SVP, Controller
$1.22M (1)
−$1.22M
2,654
$663.50K
−41.1%
RAPP EDWARD J
Director
$1.14M (4)
+$1.14M
56,352
$14.09M
+141.4%
TILTON GLENN F
Director
$496.27K (1)
+$496.27K
51,564
$12.89M
+73.8%
HURWICH THOMAS A.
VP, Controller
$335.23K (4) scheduled
−$335.23K
62,329
$15.58M
+1.4%
FREYMAN THOMAS C
Director
127,869
$31.97M
+11.4%
Hudson Thomas J
SVP, CSO, GLOBAL RESEARCH
107,267
$26.82M
+741.4%
Thakkar Roopal
EVP, R&D and CSO
52,376
$13.09M
+122.7%
Alpern Robert J
Director
35,646
$8.91M
+87.4%
WADDELL FREDERICK H
Director
30,076
$7.52M
+141.4%
BURNSIDE WILLIAM H.L.
Director
28,076
$7.02M
+168.4%
LIDDY EDWARD M
Director
26,683
$6.67M
+71.3%
Hart Brett J
Director
20,590
$5.15M
+592.3%
MEYER MELODY B
Director
17,616
$4.40M
Roberts Rebecca B
Director
14,846
$3.71M
Crum Demetris D
EVP, CHIEF HR OFFICER
7,914
$1.98M
+12.3%
Quaggin Susan E
Director
3,643
$910.75K
Davis Jennifer L.
Director
3,643
$910.75K
FALK THOMAS J
Director
2,321
$580.25K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
GONZALEZ RICHARD A
2 Mar 2021
Chairman of the Board and CEO
Exercised, kept
170,113
$54.86
$9.33M
Showing 250 of 328 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 610
Amendments (4/A) skipped 10
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 137
Sales at will 157
Transactions with no price 0
Shares from compensation/vesting 13,007,465
Sales filed before the plan box existed 144
History held since 9 Sep 2016